Cargando…
Clinical improvement after autologous bone marrow mononuclear cell transplantation
Autores principales: | Dohmann, HF, Perin, E, Silva, SA, Sousa, A, Belém, L, Rabichovisky, A, Rangel, F, Esporcatte, R, Campos, LA, Dohmann, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301001/ http://dx.doi.org/10.1186/cc2199 |
Ejemplares similares
-
Immediate and short-term safety of catheter-based autologous bone marrow-derived mononuclear cell transplantation into myocardium of patients with severe ischemic heart failure
por: Dohmann, HF, et al.
Publicado: (2003) -
Transendocardial, autologous bone-marrow cell transplant in severe, chronic ischemic heart failure
por: Dohman, HF, et al.
Publicado: (2003) -
Catheter-based transendocardial delivery of autologous bone marrow-derived mononuclear cells in patients listed for heart transplantation
por: Dohmann, HF, et al.
Publicado: (2003) -
Quality of Life (QOL) improvement following catheter-based autologous bone marrow mononuclear cell transplantation (ABM-MCT)
por: Silva, SA, et al.
Publicado: (2003) -
Endocardial delivery of bone marrow-derived mononuclear cells (BMMCs) in patients with severe ischemic heart failure
por: Dohmann, HF, et al.
Publicado: (2003)